Suppr超能文献

小鼠血小板上的α2β1整合素、糖蛋白VI(GPVI)受体和共同的FcRγ链在血栓形成模型中介导对胶原蛋白的不同反应。

α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis.

作者信息

Marjoram Robin J, Li Zhengzhi, He Li, Tollefsen Douglas M, Kunicki Thomas J, Dickeson S Kent, Santoro Samuel A, Zutter Mary M

机构信息

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States of America.

Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.

出版信息

PLoS One. 2014 Nov 21;9(11):e114035. doi: 10.1371/journal.pone.0114035. eCollection 2014.

Abstract

OBJECTIVE

Platelets express the α2β1 integrin and the glycoprotein VI (GPVI)/FcRγ complex, both collagen receptors. Understanding platelet-collagen receptor function has been enhanced through use of genetically modified mouse models. Previous studies of GPVI/FcRγ-mediated collagen-induced platelet activation were perfomed with mice in which the FcRγ subunit was genetically deleted (FcRγ-/-) or the complex was depleted. The development of α2β1-/- and GPVI-/- mice permits side-by-side comparison to address contributions of these collagen receptors in vivo and in vitro.

APPROACH AND RESULTS

To understand the different roles played by the α2β1 integrin, the GPVI receptor or FcRγ subunit in collagen-stimulated hemostasis and thrombosis, we compared α2β1-/-, FcRγ-/-, and GPVI-/- mice in models of endothelial injury and intravascular thrombosis in vivo and their platelets in collagen-stimulated activation in vitro. We demonstrate that both the α2β1 integrin and the GPVI receptor, but not the FcRγ subunit influence carotid artery occlusion in vivo. In contrast, the GPVI receptor and the FcRγ chain, but not the α2β1 integrin, play similar roles in intravascular thrombosis in response to soluble Type I collagen. FcRγ-/- platelets showed less attenuation of tyrosine phosphorylation of several proteins including RhoGDI when compared to GPVI-/- and wild type platelets. The difference between FcRγ-/- and GPVI-/- platelet phosphotyrosine levels correlated with the in vivo thrombosis findings.

CONCLUSION

Our data demonstrate that genetic deletion of GPVI receptor, FcRγ chain, or the α2β1 integrin changes the thrombotic potentials of these platelets to collagen dependent on the stimulus mechanism. The data suggest that the FcRγ chain may provide a dominant negative effect through modulating signaling pathways in platelets involving several tyrosine phosphorylated proteins such as RhoGDI. In addition, these findings suggest a more complex signaling network downstream of the platelet collagen receptors than previously appreciated.

摘要

目的

血小板表达α2β1整合素和糖蛋白VI(GPVI)/FcRγ复合物,二者均为胶原受体。通过使用基因修饰小鼠模型,对血小板-胶原受体功能的理解得到了加强。先前关于GPVI/FcRγ介导的胶原诱导血小板活化的研究是在FcRγ亚基基因缺失(FcRγ-/-)或该复合物缺失的小鼠中进行的。α2β1-/-和GPVI-/-小鼠的培育使得能够进行并列比较,以探讨这些胶原受体在体内和体外的作用。

方法与结果

为了解α2β1整合素、GPVI受体或FcRγ亚基在胶原刺激的止血和血栓形成中所起的不同作用,我们在体内内皮损伤和血管内血栓形成模型中比较了α2β1-/ -、FcRγ-/-和GPVI-/-小鼠,并在体外比较了它们的血小板在胶原刺激下的活化情况。我们证明,α2β1整合素和GPVI受体而非FcRγ亚基会影响体内颈动脉闭塞。相反,GPVI受体和FcRγ链而非α2β1整合素在对可溶性I型胶原的血管内血栓形成中发挥类似作用。与GPVI-/-和野生型血小板相比,FcRγ-/-血小板中包括RhoGDI在内的几种蛋白质的酪氨酸磷酸化的减弱程度较小。FcRγ-/-和GPVI-/-血小板磷酸酪氨酸水平的差异与体内血栓形成结果相关。

结论

我们的数据表明,GPVI受体、FcRγ链或α2β1整合素的基因缺失会根据刺激机制改变这些血小板对胶原的血栓形成潜能。数据表明,FcRγ链可能通过调节血小板中涉及几种酪氨酸磷酸化蛋白质(如RhoGDI)的信号通路发挥显性负效应。此外,这些发现表明血小板胶原受体下游的信号网络比之前认为的更为复杂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c54/4240667/474e89d05d62/pone.0114035.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验